Galore Res Inc (GALOF) 0.0253 $GALOF Galore Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Galore Res Inc (GALOF) 0.0253 $GALOF

Galore Announces Completion of Airborne Gravity and Magnetic Survey over Dos Santos Property in Zacatecas State, Mexico and a Non-Brokered Private Placement, Shares for Debt Set...
ACCESSWIRE - Fri Mar 14, 8:01AM CDT
Vancouver, B.C., / ACCESSWIRE / March 14 2014 / Galore Resources Inc. (TSX-V: GRI) is pleased to announce the completion of a 1,000 line-kilometre (625 line-mile) Helicopter Airborne Gravity Gradiometer and High Sensitivity Magnetic Survey over approximately 10,000 hectares (24,700 acres) of the Dos Santos Property in northern Zacatecas State. The survey is the first phase of a two phase exploration program to cover areas of the property underlain by rocks of the same age as those that host gold-silver-zinc-lead deposits in the district at the Penasquito mine and the Camino Rojo property. Penasquito is Goldcorp's world-class gold-silver producer and Mexico's largest mine. Galore's previous drill program at La Palma intersected encouraging geology in all twelve holes, including mineralization in three holes with metal ratios similar to the Penasquito deposit. Airborne gravity was chosen for its capability of detecting explosive diatreme intrusions like those hosting mineralization at the Penasquito mine.

Galore Changes Auditor and Sets 2013 AGM
Marketwire - Wed Jul 17, 3:00PM CDT
Galore Resources Inc. (TSX VENTURE: GRI) (the "Company") announces that effective July 12, 2013, DeVisser Gray LLP, Chartered Accountants has been appointed the Company's auditor in place of Davidson & Company, Chartered Accountants. The former auditor and new auditor confirm that there are no disagreements or unresolved issues.

Galore Announces Up to $750,000 Financing and Plans for Further Exploration at Dos Santos
Marketwire - Wed Jun 12, 2:59PM CDT
Galore Resources Inc. (TSX VENTURE: GRI) announces a non-brokered private placement of up to 15 Million units at a price of $0.05 per unit to raise gross proceeds of up to $750,000. Each unit (a "Unit") will consist of one common share and one share purchase warrant. Each warrant will be exercisable into one additional common share at a price of $0.10 per share for a period of two years from the date of closing of the financing.

GRI, EVR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri May 24, 4:28AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Galore Resources Inc (NYSE:GRI), Evercore Partners Inc (NYSE:EVR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Galore Proposes to Extend Warrants
Marketwire - Thu Feb 21, 4:38PM CST
Galore Resources Inc. (TSX VENTURE: GRI) (the "Company") proposes to extend by a further six (6) months, the expiry date of the following share purchase warrants ("Warrants"):

Galore Appoints a New Chairman and New Director
Marketwire - Fri Feb 15, 11:36AM CST
Galore Resources Inc. (TSX VENTURE: GRI) is pleased to announce that Mr. Uwe Schmidt, the Company's President, has accepted a position on Galore's Board as a Director of the Company. Additionally, Mr. Michael McMillan, the Company's Chief Executive Officer and Director has been appointed as Chairman of the Company.

Galore Closes Private Placement
Marketwire - Thu Jan 31, 1:05PM CST
Galore Resources Inc. (TSX VENTURE: GRI) announces that it has closed its non-brokered private placement offering originally announced on Monday, December 17, 2012. The total number of Units sold in the Offering were 907,500 Units priced at $0.10 per unit.

Galore Announces Up to $100,000 Financing
Marketwire - Mon Dec 17, 12:01PM CST
Galore Resources Inc. (TSX VENTURE: GRI) announces a non-brokered private placement of up to 1,000,000 units at a price of $0.10 per unit. Each unit will consist of one common share and one share purchase warrant. Each warrant will be exercisable into one additional common share at a price of $0.20 per share for a period of one year from the date of closing of the financing.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading